| Literature DB >> 21273139 |
Frank G Gilliam1, Brenda Albertson.
Abstract
Epilepsy is the most prevalent disabling neurological disorder across the life span, and is not controlled by medications in more than one-third of patients. Epilepsy surgery is an accepted treatment, with guidelines supporting utilization in patients with recurrent temporal lobe seizures after two or more trials of antiepileptic medications. Unfortunately, the average delay in presurgical evaluation of appropriate candidates is more than 20 years, and this delay has not improved in recent decades. This offers the international neurological community the opportunity to improve disability, mortality, and quality of life by more effective application of epilepsy surgery and earlier identification of potential candidates. Optimal use of MRI and video/EEG monitoring should allow cost-effective screening of persons with recurrent seizures prior to more detailed presurgical evaluation when indicated.Entities:
Mesh:
Year: 2011 PMID: 21273139 DOI: 10.1016/j.yebeh.2010.12.022
Source DB: PubMed Journal: Epilepsy Behav ISSN: 1525-5050 Impact factor: 2.937